Literature DB >> 30645718

Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome.

William Newmarch1, Madina Weiler2, Brian Casserly3.   

Abstract

The negative long-term health consequences of obesity are well known to both the medical profession and general public. Despite this, the number of obese and overweight individuals worldwide continues to steadily rise. Although obesity has long been associated with an increased risk for cardiovascular disease and mortality, the classification of a cardiomyopathy of obesity is a more recent development. Obesity cardiomyopathy is characterized as myocardial dysfunction or heart failure in obese individuals independent of other cardiovascular risk factors. The purpose of this report is to provide an overview of obesity cardiomyopathy and the proposed pathophysiological mechanisms underlying this disease, as well as to examine the link between obesity cardiomyopathy and sleep-related disorders.

Entities:  

Keywords:  Heart failure; Myocardial dysfunction; Obesity; Obesity cardiomyopathy; Obesity hypoventilation syndrome; Obstructive sleep apnea

Mesh:

Year:  2019        PMID: 30645718     DOI: 10.1007/s11845-018-01959-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  1 in total

1.  Proteomics study on the effect of silybin on cardiomyopathy in obese mice.

Authors:  Fei Wang; Zelin Li; Tiantian Song; Yujiao Jia; Licui Qi; Luping Ren; Shuchun Chen
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.